Phase II trial of topical interferon alpha-2b for the prevention of cervical cancer in women with human papilloma virus-induced low grade cervical lesions.
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2007
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Uterine cervical diseases
- Focus Therapeutic Use
- Sponsors Helix BioPharma
- 20 Dec 2007 New trial record.